Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations have been expanded to include numerous U.S. states and international sites (Madrid, Greater London), and the revision is updated to v3.3.3.SummaryDifference1%

- Check53 days agoChange DetectedPublications section text updated to say publications are automatically filled from PubMed and may not be about the study, with a revision tag showing v3.3.2. The previous wording implying PubMed sources was replaced.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page removed a government funding status notice about potential delays in updates and operating status, which previously advised users about where to check for updates (e.g., opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedNo significant additions or deletions to core study information (such as study status, eligibility criteria, enrollment, primary outcomes, or location lists) are visible between the two screenshots, indicating the page content remained essentially the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check103 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.